Egyptian Drug Co. Bought

Amoun Pharmaceuticals of < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Egypt has been acquired for approximately $460 million by Citigroup Venture Capital, Capital International Private Equity Fund IV and Concord International, according to Reuters. The deal involves the 93% of the company’s stock that is not publicly traded. The buyers are expected to make an offer for the 7% of remaining shares. < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />